Zoetis Inc. (ZTS) income statement
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3043% below fair value
$85.57+2.09 (+2.50%)
Close on Nov 18, 2026Market cap $35.36BP/E 14.1Yield 2.37%
Zoetis Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 71.5%
- Operating margin
- –
- Net margin
- 27.5%
- Return on equity, FY2025
- 65.3%
Financial strength
- Current ratio
- 3.08
- Debt to equity
- 2.87
- Debt to assets
- 60.0%
- Cash to current liabilities
- 71.6%
Valuation
- P/E ratio
- 14.1
- Price to sales
- 3.72
- Price to book
- 11.23
- Dividend yield
- 2.37%
See a number that looks wrong?